- Report
- September 2019
- 30 Pages
China
From €1974EUR$2,200USD£1,699GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
- Report
- March 2023
- 300 Pages
Global
From €2242EUR$2,499USD£1,930GBP
€3203EUR$3,570USD£2,757GBP
Proscar (finasteride) is a drug used to treat benign prostatic hyperplasia (BPH), a condition in which the prostate gland enlarges. It is classified as an endocrine and metabolic disorder drug, and is used to reduce the size of the prostate and improve urinary symptoms. Proscar works by blocking the conversion of testosterone to dihydrotestosterone, which is responsible for the growth of the prostate.
Proscar is available in both generic and brand-name forms, and is typically taken once a day. Common side effects include decreased libido, erectile dysfunction, and decreased ejaculate volume.
The Proscar market is highly competitive, with many companies offering generic versions of the drug. Companies such as Teva Pharmaceuticals, Mylan, and Sandoz are some of the major players in the market. Other companies such as Dr. Reddy's Laboratories, Sun Pharmaceuticals, and Cipla also offer generic versions of Proscar. Show Less Read more